Hyderabad: The United States Food and Drug Administration (USFDA) and the Drugs Control Administration Telangana (DCA) held their second regulatory forum on at the DCA headquarters in Vengal Rao Nagar on Tuesday, aimed at strengthening regulatory practices and public health systems.
A delegation from the USFDA participated in the forum along with senior officials of the DCA.
Officials said that discussion pertained to exchange on best regulatory practices, particularly in the inspection of medical products and improving public health outcomes. USFDA officials conducted a series of technical sessions focusing on advanced Good Manufacturing Practices (GMP), offering insights into global regulatory standards.
Officials from Telangana DCA presented their recent initiatives, inspection methodologies and emerging trends, with a focus on the implementation of Revised Schedule M norms and inspections of sterile manufacturing facilities.
According to officials, the interaction significantly enhanced the understanding of DCA inspectors regarding USFDA regulatory requirements and global best practices. The forum is expected to further strengthen collaboration between the two regulatory bodies and improve the quality and safety standards of pharmaceutical manufacturing in the region.